A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers

Biochemical Journal

Volumn 369, Issue 3, 2003, Pages 485-496

  Bergman, Marina R ^a   Cheng, Sunfa ^a   Honbo, Norman ^a   Piacentini, Lucia ^a   Karliner, Joel S ^a   Lovett, David H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gelatinase A; Hypoxia; MT1 MMP; Protein kinase C; Ventricular remodelling

Indexed keywords

ANTIBODIES; CARDIOLOGY; ELECTROPHORESIS; ENZYMES; GENES; MUTAGENESIS;

VENTRICULAR FAILURE;

BIOCHEMISTRY;

ANGIOTENSIN; ENDOTHELIN 1; GELATINASE A; HEART MUSCLE EXTRACT; INTERLEUKIN 1; LUCIFERASE; OLIGONUCLEOTIDE; SYNAPSIN I; TRANSCRIPTION FACTOR FRA 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; ENZYME REGULATION; ENZYME SYNTHESIS; FIBROBLAST; GEL MOBILITY SHIFT ASSAY; GENE MAPPING; GENETIC TRANSFECTION; HEART FAILURE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HYPOXIA; ISCHEMIC HEART DISEASE; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; SIMIAN VIRUS 40; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION;

ANGIOTENSIN II; ANIMALS; BINDING SITES; CELL HYPOXIA; CELLS, CULTURED; DIMERIZATION; ENDOTHELIN-1; FIBROBLASTS; INTERLEUKIN-1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MUTAGENESIS, SITE-DIRECTED; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

ANIMALIA; SIMIAE; SIMIAN VIRUS 40;

EID: 0037328007     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20020707     Document Type: Article

References (49)

1. Sun, Y. and Weber, K. T. (2000) Infarct scar: a dynamic tissue. Cardiovasc. Res. 46, 250-256
2. Spinale, F. G., Coker, M. L., Bond, B. R. and Zellner, J. L. (2000) Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target. Cardiovasc. Res. 46, 225-238
3. Piacentini, L., Gray, M., Honbo, N. Y., Chentoufi, J., Bergman, M. and Karliner, J. S. (2000) Endothelin-1 stimulates cardiac fibroblast proliferation through activation of protein kinase C. J. Mol. Cell. Cardiol. 32, 565-576
4. Peterson, J. T., Li, H., Dillon, L. and Bryant, J. W. (2000) Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc. Res. 46, 307-315
5. Woessner, Jr, J. F. (1999) Matrix metalloproteinase inhibition. From the Jurassic to the third millennium. Ann. N.Y. Acad Sci. 878, 388-403
6. Matrisian, L. M. (2000) Quick guide. Matrix metalloproteinases. Curr. Biol. 10, R692.
7. Nelson, A. R., Fingleton, B., Rothenberg, M. L. and Matrisian, L. M. (2000) Matrix metalloproteinases: biologic activity and clinical implications. J. Clin. Oncol. 18, 1135-1149
8. Deryugina, E. I., Bourdon, M. A., Reisfeld, R. A. and Strongin, A. (1998) Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2. Cancer Res. 58, 3743-3750
9. Vincenti, M. P. (2001) The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes. Transcriptional and posttranscriptional regulation, signal transduction and cell-type-specific expression. Methods Mol. Biol. 151, 121-148
10. Westermarck, J. and Kahari, V. M. (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13, 781-792
11. Danielsen, C. C., Wiggers, H. and Andersen, H. R. (1998) Increased amounts of collagenase and gelatinase in porcine myocardium following ischemia and reperfusion. J. Mol. Cell. Cardiol. 30, 1431-1442
12. Robert, V., Besse, S., Sabri, A., Silvestre, J. S., Assayag, P., Nguyen, V. T., Swynghedauw, B. and Delcayre, C. (1997) Differential regulation of matrix metalloproteinases associated with aging and hypertension in the rat heart. Lab. Invest. 76, 729-738
13. Spinale, F. G., Coker, M. L., Krombach, S. R., Mukherjee, R., Hallak, H., Houck, W. V., Clair, M. J., Kribbs, S. B., Johnson, L. L., Peterson, J. T. and Zile, M. R. (1999) Matrix metalloproteinase inhibition during the development of congestive heart failure: effects on left ventricular dimensions and function. Circ. Res. 85, 364-376
14. Tyagi, S. C., Kumar, S. and Katwa, L. (1997) Differential regulation of extracellular matrix metalloproteinase and tissue inhibitor by heparin and cholesterol in fibroblast cells. J. Mol. Cell. Cardiol. 29, 391-404
15. Tyagi, S. C., Smiley, L. M., Mujumdar, V. S., Clonts, B. and Parker, J. L. (1998) Reduction-oxidation (Redox) and vascular tissue level of homocyst(e)ine in human coronary atherosclerotic lesions and role in extracellular matrix remodeling and vascular tone. Mol. Cell Biochem. 181, 107-116
16. Coker, M. L., Thomas, C. V., Clair, M. J., Hendrick, J. W., Krombach, R. S., Galis, Z. S. and Spinale, F. G. (1998) Myocardial matrix metalloproteinase activity and abundance with congestive heart failure. Am. J. Physiol. 274, H1516-1523
17. Tyagi, S. C., Lewis, K., Pikes, D., Marcello, A., Mujumdar, V. S., Smiley, L. M. and Moore, C. K. (1998) Stretch-induced membrane type matrix metalloproteinase and tissue plasminogen activator in cardiac fibroblast cells. J. Cell. Physiol. 176, 374-382
18. Cheung, P.-Y., Sawicki, G., Wozniak, M., Wang, W., Radomski, M. W. and Schulz, R. (2000) Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation 101, 1833-1839
19. Thomas, C. V., Coker, M. L., Zellner, J. L., Handy, J. R., Crumbley, III, A. J. and Spinale, F. G. (1998) Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation 97, 1708-1715
20. Li, Y. Y., Feldman, A. M., Sun, Y. and McTiernan, C. F. (1998) Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation 98, 1728-1734
21. Long, C. S., Henrich, C. J. and Simpson, P. C. (1991) A growth factor for cardiac myocytes is produced by cardiac nonmyocytes. Cell Regul. 2, 1081-1095
22. Dignam, J. D., Lebovitz, R. M. and Roeder, R. G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489
23. Li, H. T., Long, C. S., Rokosh, D. G., Honbo, N. Y. and Karlliner, J. S. (1995) Chronic hypoxia differentially regulates α1-adrenergic receptor subtype mRNAs and inhibits α1-adrenergic receptor-stimulated cardiac hypertrophy and signaling. Circulation 92, 918-925
24. Harendza, S., Pollock, A. S., Mertens, P. R. and Lovett, D. H. (1995) Tissue-specific enhancer-promoter interactions regulate high level constitutive expression of matrix metalloproteinase 2 by glomerular mesangial cells. J. Biol. Chem. 270, 18786-18796
25. Brasier, A. R., Tate, J. E. and Habener, J. F. (1989) Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Biotechniques 7, 1116-1122
26. Carthew, R. W., Chodosh, L. A. and Sharp, P. A. (1985) An RNA polymerase II transcription factor binds to an upstream element in the adenovirus major late promoter. Cell 43, 439-448
27. Stetler-Stevenson, W. G. (1999) Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J. Clin. Invest. 105, 1237-1241
28. Herdegen, T. and Leah, J. D. (1998) Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Rev. 28, 370-490
29. Piacentini, L. and Karliner, J. S. (1999) Altered gene expression during hypoxia and reoxygenation of the heart. Pharmacol. Ther. 83, 21-37
30. Matrisian, L. M. (1994) Matrix metalloproteinase gene expression. Ann. N.Y. Acad. Sci. 732, 42-50
31. Qin, H., Sun, Y. and Benveniste, E. N. (1999) The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J. Biol. Chem. 274, 29130-29137
32. Mertens, P. R., Alfonso-Jaume, M. A., Steinmann, K. and Lovett, D. H. (1998) A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcription. J Biol Chem. 273, 32957-32965
33. Mertens, P. R., Harendza, S., Pollock, A. S. and Lovett, D. H. (1997) Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1. J Biol. Chem. 272, 22905-22912
34. Collier, I. E., Wilhelm, S. M., Eisen, A. Z., Marmer, B. L., Grant, G. A., Seltzer, J. L., Kronberger, A., He, C. S., Bauer, E. A. and Goldberg, G. I. (1988) H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J. Biol. Chem. 263, 6579-6587
35. Brown, P. D., Levy, A. T., Margulies, I. M., Liotta, L. A. and Stetler-Stevenson, W. G. (1990) Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res. 50, 6184-6191
36. Tryggvason, K., Hutala, P., Tuuttila, A., Chow, L., Keski-Oja, J. and Lohi, J. (1990) Structure and-expression of type IV collagenase genes. Cell Differ. Dev. 32, 307-312
37. Angel, P., Baumann, I., Stein, B., Delius, H., Rahmsdorf, H. J. and Herrlich, P. (1987) 12-0-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol. Cell. Biol. 7, 2256-2266
38. Kirstein, M., Sanz, L., Quinones, S., Moscat, J., Diaz-Meco, M. T. and Saus, J. (1996) Cross-talk between different enhancer elements during mitogenic induction of the human stromelysin-1 gene. J Biol. Chem. 271, 18231-18236
39. Huo, L. and Rothstein, T. L. (1995) Receptor-specific induction of individual AP-1 components in B lymphocytes. J. Immunol. 154, 3300-3309
40. Franklin, C. C., Sanchez, V., Wagner, F., Woodgett, J. R. and Kraft, A. S. (1992) Phorbol ester-induced amino-terminal phosphorylation of human JUN but not JUNB regulates transcriptional activation. Proc. Natl. Acad. Sci. U.S.A. 89, 7247-7251
41. Tulchinsky, E. (2000) Fos family members: regulation, structure and role in oncogenic transformation. Histol. Histopathol. (2000) 15, 921-928
42. Rupec, R. A. and Baeuerle, P. A. (1995) The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NP-κB. Eur. J. Biochem. 234, 632-640
43. Goldberg, M. A. and Schneider, T. J. (1994) Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem. 269, 4355-4359
44. Ausserer, W. A., Bourrat-Floeck, B., Green, C. J., Laderoute, K. R. and Sutherland, R. M. (1994) Regulation of c-jun expression during hypoxic and low-glucose stress. Mol. Cell. Biol. 14, 5032-5042
45. Muller, J. M., Krauss, B., Kaltschmidt, C., Baeuerle, P. A. and Rupec, R. A. (1997) Hypoxia induces c-fos transcription via a mitogen-activated protein kinase-dependent pathway. J. Biol. Chem. 272, 23435-23439
46. Webster, K. A., Discher, D. J. and Bishopric, N. H. (1993) Induction and nuclear accumulation of fos and jun proto-oncogenes in hypoxic cardiac myocytes. J. Biol. Chem. 268, 16852-16858
47. Webster, K. A., Discher, D. J. and Bishopric, N. H. (1994) Regulation of fos and jun immediate-early genes by redox or metabolic stress in cardiac myocytes. Circ. Res. 74, 679-686
48. Brand, T., Sharma, H. S., Fleischman, K. E., Duncker, D. J., McFalls, E. O., Verdouw, P. D. and Schaper, W. (1992) Proto-oncogene expression in porcine myocardium subjected to ischemia and reperfusion. Circ. Res. 71, 1351-1360
49. Walker, L. J., Craig, R. B., Harris, A. L. and Hickson, I. D. (1994) A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress. Nucleic Acids Res. 22, 4884-4889